Stronger criteria for diagnosing otitis media

Article

The American Academy of Pediatrics has issued a revised clinical practice guideline for the diagnosis and management of uncomplicated acute otitis media in children aged younger than 12 years.

The American Academy of Pediatrics (AAP) has issued a revised clinical practice guideline for the diagnosis and management of uncomplicated acute otitis media (AOM) in children aged 6 months to 12 years.

The evidence-based guideline, significantly revised and updated since originally published in 2004 and subjected to comprehensive peer review before its final approval, provides stricter diagnostic criteria for AOM based on pneumatic otoscopy findings and encourages broader use of watchful waiting before initiating antibiotics.

The guideline identifies degrees of presentation and makes recommendations for pain management, observation versus antibiotic treatment, appropriate choices of antibiotic agents, and preventive measures, all on the basis of a child’s age and severity of symptoms. It also addresses recurrent AOM that was not included in the original guideline by discouraging the prescribing of prophylactic antibiotics to reduce the frequency of recurrent AOM and suggesting the option of tympanostomy tubes in these cases.

Other recommendations advise physicians to promote pneumococcal conjugate vaccine and annual influenza vaccine for all children to help prevent upper respiratory infections that may lead to AOM; exclusive breastfeeding of infants for at least 6 months and avoiding pacifiers to reduce episodes of AOM in infancy; and lifestyle changes such as eliminating children’s exposure to passive tobacco smoke.

The AAP says the guideline is intended to assist primary care clinicians, including pediatricians, family practitioners, emergency department physicians, otolaryngologists, physician assistants, and nurse practitioners, with the accurate diagnosis and initial treatment of a child presenting with AOM and is not meant to establish protocol, be a sole source of guidance, or replace clinical judgment.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
© 2025 MJH Life Sciences

All rights reserved.